Skip to main content

Table 2 Clinical data of patients

From: Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients

 n N = 67CTC positive (%)p-valueAR-positive CTC (%)p-value
Total6737 (55) 16 (43) 
 Menopausal status  0.40 0.68
premenopausal127 (58) 4 (57) 
 postmenopausal5328 (53) 11 (39) 
 unknown22 (100) 1 (50) 
Line of treatment  0.75 0.30
 1st2615 (58) 8 (53) 
  ≥ 2nd4122 (54) 8 (36) 
IHC tumour type  0.94 0.56
 TNBC106 (60) 2 (33) 
 HR+/HER2-5530 (54) 14 (47) 
 HR+/HER2 + a21 (50) 0 
Site of metastasis  0.65 0.44
 bone only148 (57) 4 (50) 
 other site5228 (54) 11 (39) 
 unknown11 (100) 1 (100) 
  1. ascreening failure